Sunday, October 31, 2010
Getting final approval for the study is taking longer than I would like. Dr E referred to it as "bureaucracy". They have completed an Emergency Investigational New Drug application. Now waiting for review by the IRB - I assume that is an internal review board. Apparently, this IRB meets Nov 9. So...it looks like we will have an answer then. The drug has been in the news and seems to now have a name - crizotinib. I don't wait well. But...that's my only option.